[18F]FPyGal

N/A

Report date: 2025/12/01 17:16:52

NME

Base Information

Drug Name[18F]FPyGal

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F +[5]

Mechanisms of ActionDiagnostic imaging enhancersRadionuclide imaging enhancersBeta-galactosidase binders

TargetsBeta-galactosidase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Hospital Tuebingen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Hospital Tuebingen

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A